Nanostics AI ClarityDX Prostate Study Improves Cancer Detection
EDMONTON, Alberta, April 20, 2026 Nanostics Inc. has announced the publication of a peer-reviewed study validating its AI-powered ClarityDX®...
AI diagnostics
Advertisement
Tempus AI, Predicta Expand Genomics Test for Blood Cancer
Chicago, Illinois, U.S. | April 15, 2026 Tempus AI, Inc., in collaboration with Predicta Biosciences, has announced the expansion...
TOBY Gains FDA Breakthrough Status for MCED Test
AUSTIN, TEXAS, USA, April 14, 2026 TOBY, Inc. has received FDA Breakthrough Device Designation for its urine-based Multi-Cancer Early...
Anumana Gains FDA Clearance for ECG-AI Amyloidosis Tool
CAMBRIDGE, Mass., April 8, 2026 Anumana, Inc. has received U.S. FDA clearance for its ECG-AI™ algorithm designed to detect...
bioAffinity CyPath Lung Test Improves Cancer Diagnosis
SAN ANTONIO, TX, March 17, 2026 bioAffinity Technologies, Inc. has released a new clinical case study demonstrating how its...
Advertisements
Caris Detect Achieves 99% Specificity in MCED
IRVING, Texas, February 26, 2026 Caris Life Sciences® (NASDAQ: CAI) announced an interim readout from its Achieve 1 clinical...
Breakthrough Brain Biomarker Detects Neuroprotection
New York, USA & Tel Aviv, Israel — February 26, 2026 NeuraLight has announced the presentation of next-generation brain-function...
FDA Clears PhenoMATRIX for Digital Microbiology Labs
PARMA, ITALY — February 17, 2026 Copan Diagnostics announced that its AI-enabled microbiology imaging system PhenoMATRIX has received U.S....
FDA Clears Neurophet AQUA AD Plus in Alzheimer’s AI
Seoul, South Korea — February 6, 2026 Neurophet has announced that the U.S. Food and Drug Administration (FDA) has...
FDA Clears Scaida AI Tool to Speed Intracranial Bleed Triage
mlHealth 360 has received U.S. FDA 510(k) clearance for Scaida BrainCT-ICH, the first Canada-developed AI-powered triage solution designed to...
Advertisement
